VEGFA and age-related macular degeneration: Although neovascular AMD represents only 10–15% of the overall prevalence of AMD, it was responsible for more than 80% of cases of severe visual loss or legal blindness before the advent of anti-vascular endothelial growth factor (VEGF) therapy [2].